ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,352.96
-0.02%
Dow Jones
38,886.17
0.20%
US Dollar vs MXN
17.87831
-0.05%
Brent Oil
79.925
0.06%
Bitcoin
70,797.96
0.05%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Talaris Therapeutics Inc (TALS)

  7. Talaris Therapeutics Inc (TALS) Noticias

TALS

Talaris Therapeutics (TALS)

Talaris Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:TALS
FechaHoraFuenteTítuloSímboloCompañía
19/04/202415:05Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:TALSTalaris Therapeutics Inc
19/04/202415:04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TALSTalaris Therapeutics Inc
19/04/202415:02Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TALSTalaris Therapeutics Inc
19/03/202416:10Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TALSTalaris Therapeutics Inc
19/03/202416:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TALSTalaris Therapeutics Inc
19/03/202406:09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TALSTalaris Therapeutics Inc
20/11/202317:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TALSTalaris Therapeutics Inc
06/11/202315:30Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:TALSTalaris Therapeutics Inc
30/10/202315:15Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:TALSTalaris Therapeutics Inc
17/10/202316:47GlobeNewswire Inc.Talaris Therapeutics Announces Stockholder Approval of Merger with Tourmaline BioNASDAQ:TALSTalaris Therapeutics Inc
10/10/202315:32Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:TALSTalaris Therapeutics Inc
10/10/202315:30Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:TALSTalaris Therapeutics Inc
06/10/202319:01Dow Jones NewsStocks to Watch: Shift Technologies, Talaris Therapeutics, Lockheed MartinNASDAQ:TALSTalaris Therapeutics Inc
06/10/202316:09GlobeNewswire Inc.Talaris Therapeutics Declares Special Dividend In Connection with Proposed Merger with Tourmaline BioNASDAQ:TALSTalaris Therapeutics Inc
04/10/202307:30GlobeNewswire Inc.New York Blood Center Enterprises Acquires Commercial-Scale Cell & Gene Therapy Development and Manufacturing Facilities from Talaris TherapeuticsNASDAQ:TALSTalaris Therapeutics Inc
15/09/202305:31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TALSTalaris Therapeutics Inc
14/09/202323:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TALSTalaris Therapeutics Inc
13/09/202315:28Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:TALSTalaris Therapeutics Inc
14/08/202306:53Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TALSTalaris Therapeutics Inc
22/06/202308:12Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:TALSTalaris Therapeutics Inc
22/06/202306:30GlobeNewswire Inc.Talaris Therapeutics and Tourmaline Bio Announce Merger AgreementNASDAQ:TALSTalaris Therapeutics Inc
14/06/202318:02Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TALSTalaris Therapeutics Inc
30/05/202315:52Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TALSTalaris Therapeutics Inc
26/05/202306:00GlobeNewswire Inc.Talaris Therapeutics Announces Leadership TransitionNASDAQ:TALSTalaris Therapeutics Inc
15/05/202315:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:TALSTalaris Therapeutics Inc
28/04/202315:42Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:TALSTalaris Therapeutics Inc
28/04/202315:10Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:TALSTalaris Therapeutics Inc
28/04/202315:09Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:TALSTalaris Therapeutics Inc
27/04/202313:20Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:TALSTalaris Therapeutics Inc
07/04/202315:20Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:TALSTalaris Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TALS

Su Consulta Reciente

BIT
P1ZYU6
NLBNPIT1ZYU6 20991231 16...
BIT
P1RXW1
NLBNPIT1RXW1 20241220 4
BIT
P1RYW9
NLBNPIT1RYW9 20241220 18
USOTC
DOMVF
Dogus Otomotiv Servis Ve... (PK)
EU
PEV6P
Banque Palatine null
BIT
P1YD90
NLBNPIT1YD90 20991231 33...
LSE
15CN
Macquarie Gp 31
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados